Ajanta Pharma Limited — Bhasma Exporter Profile
Indian Pharmaceutical Exporter · #1 for Bhasma · $73.6K export value · DGFT Verified
Ajanta Pharma Limited is the #1 Indian exporter of Bhasma with $73.6K in export value and 27 verified shipments. Ajanta Pharma Limited holds a 17.8% market share in Bhasma exports across 3 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Bhasma Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Bhasma?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $30.8K | 2 | 41.8% |
| KYRGYZSTAN | $22.8K | 11 | 31.0% |
| KYRGHYSTAN | $19.5K | 12 | 26.5% |
| KAZAKHSTAN | $345 | 1 | 0.5% |
| KAZAKISTAN | $195 | 1 | 0.3% |
Ajanta Pharma Limited exports Bhasma to 5 countries. The largest destination is FRANCE accounting for 41.8% of Ajanta Pharma Limited's Bhasma shipments, followed by KYRGYZSTAN (31.0%) and KYRGHYSTAN (26.5%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bhasma from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANET PHARMA SA | FRANCE | $30.8K | 2 |
| FARMAMIR LLC | KYRGHYSTAN | $18.9K | 7 |
| NEMAN # PHARM LLC | KYRGHYSTAN | $11.0K | 5 |
| ERAI PHARM LLC | KYRGHYSTAN | $6.4K | 6 |
| #ERAI PHARM# LLC | KYRGHYSTAN | $2.4K | 2 |
| MED SERVICE KG LLC | KYRGYZSTAN | $2.2K | 1 |
| OCOO ALCOR-COMPANY | KYRGHYSTAN | $1.5K | 2 |
| BRANCH OF AJANTA PHARMA LIMITED IN THE REPUBLIC | KAZAKHSTAN | $345 | 1 |
| BRANCH OF AJANTA PHARMA LIMITED | KAZAKISTAN | $195 | 1 |
Ajanta Pharma Limited supplies Bhasma to 9 buyers globally. The largest buyer is PLANET PHARMA SA (FRANCE), followed by FARMAMIR LLC (KYRGHYSTAN) and NEMAN # PHARM LLC (KYRGHYSTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bhasma Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $318.5K worth of Bhasma through 720 shipments from 76 suppliers to 34 countries, serving 146 buyers globally. Ajanta Pharma Limited contributes $73.6K to this total, accounting for 17.8% of India's Bhasma exports. Ajanta Pharma Limited ships Bhasma to 5 countries through 9 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Bhasma Exports?
Ajanta Pharma Limited's average Bhasma shipment value is $2.7K per consignment, based on 27 shipments totaling $73.6K. The largest destination is FRANCE (41.8% of Ajanta Pharma Limited's Bhasma exports).
How Does Ajanta Pharma Limited Compare to Other Indian Bhasma Exporters?
Ajanta Pharma Limited ranks #1 among 76 Indian Bhasma exporters with a 17.8% market share. The top 3 exporters are AJANTA PHARMA LIMITED ($73.6K), SHREE DHOOTAPAPESHWAR LIMITED ($55.1K), PATANJALI AYURVED LIMITED ($37.8K). Ajanta Pharma Limited processed 27 shipments to 3 destination countries.
What Bhasma Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AJANTA'S STAMINA CAPS[4720PACKX3X10=141600 CAPS]EACH CAPS CONT:SILAJEET 32 MG, BANG BHASMA 10 MG,EXT. OF AS PER INV | $25.7K | 1 |
| APCOSULE CAPSULES [2400PACKx100=240000 CAPS]EACH CAPS CONT:MANDUR BHASMA 33 MG,AQUEOUS EXTRACT OF : CAPPARIS AS PER INV | $6.8K | 1 |
| AJANTA STAMINA CAPSULES [960PACKx3x10=28800 CAPSS]EACH CAPS CONT:SILAJEET 32 MGBANG BHASMA 10 MG EXT. OF AS PER INV | $5.0K | 1 |
| APCOSULE CAPSULES[1,500PACKX100=150000 CAPS][EACH CAPS CONT:MANDUR BHASMA 33 MG,AQUEOUS EXTRACT OF :AS PER INVOICENOS | $3.4K | 1 |
| APCOSULE CAPSULES[1000PACKx100= 100000 CAPS]EACH CAPS CONT:MANDUR BHASMA 33 MG,AQUEOUS EXTRACT OF:CAPPARIS AS PER INV | $3.2K | 1 |
| APCOSULE CAPSULES[500PACKX100=50000 CAPS]EACH CAPS CONT:MANDUR BHASMA 33 MG, AQUEOUS EXTRACT OF : CAPPARIS AS PER INV | $3.1K | 3 |
| APCOSULE CAPSULES 1500PACKx100 150000 CAPS EACH CAPS CONT MANDUR BHASMA 33 MG AQUEOUS EXTRACT OF CAPPARIS AS PER INV | $2.9K | 1 |
| APCOSULE CAPSULES[400PACKx100=40000 CAPS]EACH CAPS CONT:MANDURBHASMA 33 MG, AQUEOUS EXTRACT OF:CAPPARIS AS PER INV | $2.7K | 3 |
| APCOSULE CAPSULES[1200PACKx100=120000 CAPS]EACH CAPS CONT:MANDUR BHASMA 33 MG,AQUEOUS EXTRACT OF : CAPPARIS AS PER INV | $2.4K | 1 |
| APCOSULE CAPSULES[1000PACKX100= 100000 CAPS]EACH CAPS CONT:MANDUR BHASMA 33 MG,AQUEOUS EXTRACT OF:CAPPARIS AS PER INV | $2.4K | 1 |
Ajanta Pharma Limited exports 23 distinct Bhasma formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AJANTA'S STAMINA CAPS[4720PACKX3X10=141600 CAPS]EACH CAPS CO with 1 shipments worth $25.7K.
How Does Ajanta Pharma Limited Compare to Nearest Bhasma Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED ★ | $73.6K | 27 | 3 | $2.7K |
| 2 | SHREE DHOOTAPAPESHWAR LIMITED | $55.1K | 123 | 2 | $448 |
| 3 | PATANJALI AYURVED LIMITED | $37.8K | 14 | 1 | $2.7K |
Ajanta Pharma Limited ranks #1 among 76 Indian Bhasma exporters. Average shipment value of $2.7K compared to the market average of $4.2K. The closest competitors by value are SHREE DHOOTAPAPESHWAR LIMITED and PATANJALI AYURVED LIMITED.
Which Indian Ports Ship Bhasma Exports?
| Port | Shipments | % Share |
|---|---|---|
| RAXAUL (INRXLB) | 98 | 13.6% |
| RAXAUL | 76 | 10.6% |
| NHAVA SHEVA SEA (INNSA1) | 48 | 6.7% |
| DELHI AIR CARGO ACC (INDEL4) | 46 | 6.4% |
| COCHIN SEA (INCOK1) | 44 | 6.1% |
| DELHI AIR | 28 | 3.9% |
| SONAULI LCS | 28 | 3.9% |
| Raxaul | 28 | 3.9% |
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Bhasma Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Bhasma, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bhasma — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bhasma shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 27 individual customs records matching Ajanta Pharma Limited exporting Bhasma, covering 23 formulations to 5 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 34+ countries, 146+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bhasma Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Bhasma exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Bhasma Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bhasma. For current shipment-level data, contact TransData Nexus.